Skip to main content

Table 5 Adverse events in the dose escalation study

From: Low dose chloroquine decreases insulin resistance in human metabolic syndrome but does not reduce carotid intima-media thickness

Adverse eventSubjects (%)
Total subjects with any event24 (69)
Subjects with a serious adverse event0 (0)
Total adverse events57 (100)
Study related14 (25)
 IV placement difficulties1 (1.8)
 IV infiltration1 (1.8)
 Phlebitis1 (1.8)
 Skin reaction to tape1 (1.8)
 Extremity erythema due to BP cuff1 (1.8)
 Vasovagal episode with IV placement1 (1.8)
 Incorrect stable isotope administered1 (1.8)
 Nausea3 (5)
 Anemia4 (7)
Not study related43 (75)
 Infectious15 (26)
 Allergy/immunology3 (5)
 Musculoskeletal8 (14)
 CNS3 (5)
 Psychiatric5 (9)
 Cardiovascular2 (4)
 GI4 (7)
 Metabolic3 (5)
  1. Parentheses denote %